 | Abeona Therapeutics Inc. | |||
| NCM : ABEO || Location: United States | ||||
$3.3+0.11 (+3.45%) |
1.14 M | 3.2 - 3.38 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 2.061 M |
| March 28, 2024 | 1.994 M |
| March 15, 2024 | 1.704 M |
| Feb. 29, 2024 | 1.642 M |
| Feb. 15, 2024 | 1.562 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.48 | -0.77 | -60.62% |
| 09/30/2023 | -0.54 | -0.48 | 10.65% |
| 06/30/2023 | -0.69 | -0.92 | -32.64% |
| 03/31/2023 | -0.59 | -0.54 | 8.72% |
| 12/31/2022 | -0.76 | 1.53 | 300.00% |
ABEO Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 27.355M | Shares Float | 19.079M |
| Short Float | 2.061M | Market Cap | 87.26M |
| Institution ownership | 59.94% | Insider ownership | 4.937% |
| Earnings Date | 05/10/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -2.53 | Forward EPS | -2.15 |